Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 07, 2026 09:01 ET | Source: Berger Montague

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

PHILADELPHIA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX)...
January 06, 2026 10:19 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

LOS ANGELES, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the "Company") (NASDAQ: TLX) investors of a class action on behalf of investors...
January 05, 2026 09:50 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
January 05, 2026 09:09 ET | Source: Hagens Berman Sobol Shapiro LLP

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
January 01, 2026 11:35 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 30, 2025 10:13 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Telix Pharmaceuticals Limited, (“Telix” or the "Company") (NASDAQ: TLX) investors of a class action on behalf of investors...
December 29, 2025 16:48 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX 11-DAY DEADLINE ALERT: Hagens Berman Urges Telix (TLX) Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
December 29, 2025 10:20 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 26, 2025 10:10 ET | Source: Schall Law

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 25, 2025 12:00 ET | Source: Hagens Berman Sobol Shapiro LLP

TLX CLASS ACTION DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Investors who lost money in TLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.